Warning: Use of undefined constant KT_BSEO - assumed 'KT_BSEO' (this will throw an Error in a future version of PHP) in /homepages/46/d347802020/htdocs/los-angeles-dentist-blog/wp-content/plugins/keyword-tag-wrapper/keyword-tagger-bseo.php on line 10

Warning: Use of undefined constant KT_BSEO_DB_VERSION - assumed 'KT_BSEO_DB_VERSION' (this will throw an Error in a future version of PHP) in /homepages/46/d347802020/htdocs/los-angeles-dentist-blog/wp-content/plugins/keyword-tag-wrapper/keyword-tagger-bseo.php on line 11

Warning: Use of undefined constant wp_cumulus_widget - assumed 'wp_cumulus_widget' (this will throw an Error in a future version of PHP) in /homepages/46/d347802020/htdocs/los-angeles-dentist-blog/wp-content/plugins/wp-cumulus/wp-cumulus.php on line 375
Cascade Medical Enterprises, LLC Announces the Sale of Their Orthopedic Business | Dentist Beverly Hills, Dentist Los Angeles
Dentist Los Angeles | Dentist Beverly Hills | General Dentist | Cosmetic Dentist | Dental Implant | Dental Office
 

www.zdentalgroup.com

 

Cascade Medical Enterprises, LLC Announces a Sale of Their Orthopedic Business

Posted by Z Dental Group - January 6th, 2012

WAYNE, N.J., Jan. 6, 2012 /PRNewswire around COMTEX/ —
Cascade Medical Enterprises, LLC (CME), a heading association with exclusive platelet-rich plasma (PRP) and platelet-rich fibrin pattern (PRFM) record for use in orthopedic recovering applications in soothing hankie and bone repair, announced a sale of their record to Musculoskeletal Transplant Foundation (MTF) and placement by ConMed Linvatec for a worldwide orthopedic, dental, and wound caring markets.

CME has had a prolonged collaborative US placement attribute with MTF for a sale of their products in a sports medicine market. This partnership has enabled a companies to grasp a infirm marketplace participation substantiating CME as a science-based provider of a singular record for a collection, preparation, and smoothness of an autologous blood-derived platelet and fibrin biologic. The CME record has been grown into procession specific systems and kits, marketed as a CASCADE® System. The pivotal exclusive aspects of a CASCADE® record are a ability to furnish liquid, gel, and surface formats for a PRP and PRFM to accommodate a needs of a specific procession technique requirements.

The CASCADE® System is an FDA 510(k) privileged device that is designed to be used for a protected and fast credentials of autologous PRP from a tiny representation of blood during a studious indicate of care. The PRP can be churned with autograft and allograft bone before to a concentration to an orthopedic surgical site as deemed required by a clinical use requirements.

Autologous PRP and PRFM are biologic preparations that are subsequent from a patient’s possess blood. Platelets are famous to enclose expansion factors that kindle a body’s healthy recovering of soothing hankie and bone. The collection and thoroughness of these factors from a tiny representation of blood regulating systems that are safe, easy to use, and designed to maximize opening are singular to a CASCADE® technology. In further to a platelets, a CASCADE® System collects and prepares a fibrin pattern that acts as a skeleton to capacitate dungeon emigration into a correct site. Numerous systematic and clinical papers have been published.

See MTF’s web site:
www.platelettherapy.com for some-more information

Tony Dimun, Chairman of CME pronounced “We are gratified that a partnership with MTF has led to this sparkling event to enhance a strech of a record with a sale of a record to MTF and placement by ConMed Linvatec on a worldwide basis. We are unapproachable of a accomplishments in partnership with MTF in bringing this sparkling autologous record to a worldwide market.”

Nicholas Grippi, President and owner of CME, pronounced “Our prolonged attribute with MTF in building science-based support for a record has determined CME’s approval as a heading corner of autologous biologics therapy.”

Frank DeBernardis, CEO of CME, pronounced “The MTF Sports Medicine Marketing and Sales classification did an glorious pursuit of pioneering a markets for autologous biologics. We are gratified to continue a support for MTF and ConMed Linvatec in a ongoing product growth of this sparkling technology. Additionally, this attribute will capacitate CME to concentration on a rising Aesthetic Factors® and Vertical Spine(TM) business ventures.”

“MTF has been gratified to work with CME over a past several years compelling their singular PRP technology. With this acquisition, we will now have a event to severely enhance a graduation of CASCADE® PRP by a new partnership with ConMed Linvatec for a worldwide orthopedic, dental, and wound caring markets,” pronounced Bruce Stroever, President and CEO of MTF.

SOURCE Cascade Medical Enterprises, LLC

Copyright (C) 2012 PR Newswire. All rights reserved

Comtex

Shared Post

    Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

    Leave a Reply

    You must be logged in to post a comment.

    Blog Home